Brief: Nextcell Pharma Q4 Pre-Tax Loss Widens To SEK 8.0 Mln
31/10/2019 07:55
Oct 31 (Reuters) - NextCell Pharma AB NXTCL.TE :
* Q4 OPERATING REVENUE SEK 0.6 MILLION VERSUS SEK 0.1
MILLION YEAR
AGO
* Q4 PRE-TAX LOSS SEK 8.0 MILLION VERSUS LOSS SEK 3.4
MILLION YEAR
AGO
Source text for Eikon: ID:nWkr6fYPBC
Further company coverage: NXTCL.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln